Our top pick for
DRDGOLD Limited is a gold business based in the US. DRDGOLD shares (DRD) are listed on the NYSE and all prices are listed in US Dollars. DRDGOLD employs 951 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$8.01 - $17.21|
|50-day moving average||$9.92|
|200-day moving average||$10.67|
|Wall St. target price||$19.00|
|Dividend yield||$10 (94.61%)|
|Earnings per share (TTM)||$1.01|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing DRDGOLD stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DRDGOLD's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DRDGOLD's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, DRDGOLD shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
DRDGOLD's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2 billion.
The EBITDA is a measure of a DRDGOLD's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5.1 billion|
|Operating margin TTM||32.87%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||19.48%|
|Return on equity TTM||32.88%|
|Market capitalisation||$850.1 million|
TTM: trailing 12 months
There are currently 698,871 DRDGOLD shares held short by investors – that's known as DRDGOLD's "short interest". This figure is 2.3% down from 715,526 last month.
There are a few different ways that this level of interest in shorting DRDGOLD shares can be evaluated.
DRDGOLD's "short interest ratio" (SIR) is the quantity of DRDGOLD shares currently shorted divided by the average quantity of DRDGOLD shares traded daily (recently around 238522.52559727). DRDGOLD's SIR currently stands at 2.93. In other words for every 100,000 DRDGOLD shares traded daily on the market, roughly 2930 shares are currently held short.
However DRDGOLD's short interest can also be evaluated against the total number of DRDGOLD shares, or, against the total number of tradable DRDGOLD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DRDGOLD's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 DRDGOLD shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable DRDGOLD shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against DRDGOLD.
Find out more about how you can short DRDGOLD stock.
Dividend payout ratio: 77.15% of net profits
Recently DRDGOLD has paid out, on average, around 77.15% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.9% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), DRDGOLD shareholders could enjoy a 4.9% return on their shares, in the form of dividend payments. In DRDGOLD's case, that would currently equate to about $10 per share.
DRDGOLD's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
DRDGOLD's most recent dividend payout was on 17 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 3 March 2021 (the "ex-dividend date").
DRDGOLD's shares were split on a 1:10 basis on 22 July 2007. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DRDGOLD shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for DRDGOLD shares which in turn could have impacted DRDGOLD's share price.
Over the last 12 months, DRDGOLD's shares have ranged in value from as little as $8.0088 up to $17.2108. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while DRDGOLD's is 1.3442. This would suggest that DRDGOLD's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
DRDGOLD Limited, a gold mining company, engages in the surface gold tailings retreatment business in South Africa. The company is involved in the exploration, extraction, processing, and smelting activities. It recovers gold from surface tailings in the Witwatersrand basin in Gauteng province. The company was founded in 1895 and is headquartered in Johannesburg, South Africa. .
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
Everything we know about the Soulgate IPO, plus information on how to buy in.
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
Everything we know about the FIGS IPO, plus information on how to buy in.
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.